Prolanis Influence on Decreasing Blood Pressure of Hypertension Patients in Puskesmas Pandak II Bantul 2017

Florentina Sita Murti; Hari Kusnanto Josef; Wahyudi Istiono

doi:10.22146/rpcpe.46016

Prolanis Influence on Decreasing Blood Pressure of Hypertension Patients in Puskesmas Pandak II Bantul 2017

https://doi.org/10.22146/rpcpe.46016

Florentina Sita Murti^(1*), Hari Kusnanto Josef⁽²⁾, Wahyudi Istiono⁽³⁾

(1) Puskesmas Imogiri I Bantul; Yogyakarta; Indonesia
(2) Department of Family and Community Medicine; Faculty of Medicine, Public Health, and Nursing; Universitas Gadjah Mada; Indonesia
(3) Department of Family and Community Medicine; Faculty of Medicine, Public Health, and Nursing; Universitas Gadjah Mada; Indonesia
(*) Corresponding Author

Abstract

Background: People with hypertension over age 25 years reached 40% in 2008 according to the World Health Organization and 75% occurred in developing countries. Hypertension management must be focused on first-rate health care which could reduce death-risk, disabilities, and the cost burden. Badan Pengelola Jaminan Social obliges every first-rate health care to have to apply Program Pengelolaan Penyakit Kronis (Prolanis). Objectives: This study aims to determine the difference of decreased blood pressure in Prolanis and Non-Prolanis groups in Puskesmas Pandak II. Methods: This quantitative research with cohort retrospective design used secondary data of hypertension patients who are following Prolanis compared with those who are not in Puskesmas Pandak II. Data covered characteristics of patients, blood pressure, and Body-Mass Index (BMI) over one year. The analysis used repeated measures ANOVA. Results: The comparison with the treatment group showed significant differences in blood pressure variable, diastolic pressure variable, and BMI, interaction and measureable differences during the study period in all three variables. There was an uptrend in the Non-Prolanis group and a downtrend in the Prolanis group. Conclusions: Decreased blood pressure of patients with hypertension is better in Prolanis than Non-Prolanis groups.

Keywords

decreased blood pressure; hypertension; prolanis

Full Text:

PDF

References

1.World Health Organization. How public health stakeholders can tackle hypertension. A Global Brief on Hypertension. Geneva: WHO. 2013.

2.Agency For Health Research And Development. Basic Health Research 2013. National report. 2013:1-384.

3.Bantul Health Office. Bantul regency health profile in 2016. Bantul: Bantul Health Office. 2016.

4.Campbell NR, Khalsa T, World Hypertension League Executive: Lackland DT, Niebylski ML, Nilsson PM, Redburn KA, Orias M, Zhang XH, International Society of Hypertension Executive: Burrell L. High blood pressure 2016: why prevention and control are urgent and important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Nephrology. The Journal of Clinical Hypertension. 2016 Aug; 18(8):714-7.

5.James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama. 2014 Feb 5;311(5):507-20.

6.Sanyoto DV, Syah NA. The Role of Primary Care Physicians (DLP) in community care. Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer);1(1):3-5.

7.Schröders J, Wall S, Hakimi M, Dewi FS, Weinehall L, Nichter M, et al. How is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis. PloS One. 2017 Jun 20; 12(6):e0179186.

8.Kosasih H. Clinical pathophysiology. Jakarta: Binarupa Aksara. 2013.

9.Ministry of Health Republic of Indonesia. Health insurance system. Available from: http://www.depkes.go.id/article/view/13060100016/ sosialisasi-jaminan-kesehatan-nasional.html.2014

10.Health Social Guarantee Organizing Agency. Prolanis (chronic disease management program) practical guide. Jakarta: Health Social Guarantee Organizing Agency. 2014.

11.Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of sample size in health studies (trans vers). Yogyakarta: Gadjah Mada University Press. 1997.

12.Dahlan MS. Sample size and method of sampling 3rd ed. Jakarta: Salemba Medika. 2010:29-30.

13.Puskesmas Pandak II Bantul. Puskesmas Pandak II Profile 2016. Bantul. 2016.

14.Kaplan NM. Hypertension in the population at large. Kaplan’s Clinical Hypertension. 2002:1-24.

15.Rahajeng E, Tuminah S. Prevalence of hypertension and determinants in indonesia. Indonesian medical magazine. 2009 Dec; 59(12):580-7.

16.Morisky DE, Levine DM, Green LW, Shapiro S, Russell RP, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. American Journal of Public Health. 1983 Feb;73(2):153-62.

17.Shayesteh H, Mirzaei A, Sayehmiri K, Qorbani M, Mansourian
M. Effect of education intervention on lifestyle of patients with hypertension among the rural population of Lorestan Province. Journal of Lifestyle Medicine. 2016 Sep;6(2):58.

18.Indonesian Heart Association. Guidelines for managing hypertension in cardiovascular diseases. Jakarta: Indonesian Heart Association. 2015.

19. Yan LD, Chirwa C, Chi BH, Bosomprah S, Sindano N, Mwanza M, et al. Hypertension management in rural primary care facilities in Zambia: a mixed methods study. BMC Health Services Research. 2017 Dec;17(1):111.

DOI: https://doi.org/10.22146/rpcpe.46016